Cargando...
Proteasomal adaptations underlying carfilzomib-resistance in human bone marrow plasma cells
Donor-specific antibodies (DSAs) have a deleterious effect on allografts and remain a major immunologic barrier in transplantation. Current therapies to eliminate DSAs are ineffective in highly human leukocyte antigen (HLA)-sensitized patients. Proteasome inhibitors have been employed as a strategy...
Gardado en:
| Publicado en: | Am J Transplant |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6984988/ https://ncbi.nlm.nih.gov/pubmed/31595669 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ajt.15634 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|